| <P style="BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 0cm 0cm 0pt; WORD-SPACING: 0px; FONT: 14px/21px simsun; TEXT-TRANSFORM: none; COLOR: rgb(85,85,85); WORD-BREAK: normal; TEXT-INDENT: 24pt; PADDING-TOP: 0px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: white; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 0px; WORD-WRAP: normal; border-image: initial; orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px; background-origin: initial; background-clip: initial" align=left><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">11</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">月</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">19</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">日</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">，美国</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">FDA</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">批准葛兰素史克公司的</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">Promacta</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">（</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">e</SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN"><FONT color=#555555>ltrombopag</FONT></SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">）用于治疗慢性丙型肝炎患者血小板减少（血小板计数低），以使他们能够启动和维持干扰素为基础的治疗。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">Promacta</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">是因低血小板计数而不适合进行干扰素为基础的治疗患者的首个支持性护理治疗药物。</SPAN><FONT size=3><FONT color=#333333><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal"><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 24px; WORD-WRAP: normal"><SPAN lang=EN-US style="WORD-BREAK: normal; LINE-HEIGHT: 24px; WORD-WRAP: normal" xml:lang="EN-US"><FONT style="WORD-BREAK: normal; LINE-HEIGHT: 24px; WORD-WRAP: normal" face=Arial>Promacta</FONT></SPAN></SPAN></SPAN><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 21px; WORD-WRAP: normal"><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">与</SPAN></SPAN></FONT></FONT><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">干扰素为基础的治疗联用已被证明能够改善患者实现持续病毒学应答（</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">SVR</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">）或病毒治愈效果。</SPAN></P>
<P style="BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 0cm 0cm 0pt; WORD-SPACING: 0px; FONT: 14px/21px simsun; TEXT-TRANSFORM: none; COLOR: rgb(85,85,85); WORD-BREAK: normal; TEXT-INDENT: 24pt; PADDING-TOP: 0px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: white; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 0px; WORD-WRAP: normal; border-image: initial; orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px; background-origin: initial; background-clip: initial" align=left><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">Promacta</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">用于</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">丙型肝炎血小板减少有若干限制：①不用于使血小板正常化之目的；②仅用于血小板减少症的程度限制了干扰素治疗慢性丙型肝炎患者；③<FONT size=3><FONT color=#333333><STRONG style="FONT-WEIGHT: bold"><SPAN style="FONT-WEIGHT: normal; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">与获准用于治疗</SPAN></STRONG><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 24px; WORD-WRAP: normal">慢性丙型肝炎基因型</SPAN></FONT></FONT></SPAN><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 21px; WORD-WRAP: normal"><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">1</SPAN></SPAN><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 21px; WORD-WRAP: normal"><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">感染患者的直接作用</SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">抗病毒剂联合使用的安全性和疗效尚未确定。</SPAN></P>
<P style="BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 0cm 0cm 0pt; WORD-SPACING: 0px; FONT: 14px/21px simsun; TEXT-TRANSFORM: none; COLOR: rgb(85,85,85); WORD-BREAK: normal; TEXT-INDENT: 24pt; PADDING-TOP: 0px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: white; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 0px; WORD-WRAP: normal; border-image: initial; orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px; background-origin: initial; background-clip: initial" align=left><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">慢性丙型肝炎影响公众共健康。那些低血血小板计数的慢性丙型肝炎患者启用干扰素为基础的治疗可使血小板问题更加恶化。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">Promacta</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">的获准显然可使这里患者受益，使能获得积极治疗。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US"><BR><FONT style="WORD-BREAK: normal; LINE-HEIGHT: 24px; WORD-WRAP: normal"><FONT size=3><FONT color=#333333><FONT face=Arial><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 24px; WORD-WRAP: normal"> <WBR> <WBR> <WBR></SPAN><SPAN class=Apple-converted-space> </SPAN>Promacta</FONT></FONT></FONT></FONT></SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">的获准建立在</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">ENABLE</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">（<SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">e</SPAN></SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">ltrombopag</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">使</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">C</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">型肝炎相关的肝病</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">E</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">受试者启动和维持干扰素抗病毒治疗的益处）</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">1</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">和</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">2</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">这两项</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">III</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">期随机</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">-</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">双盲</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">-</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">安慰剂对照的多中心研究基础上。总共招募了</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">1521</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">名血小板计数</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US"><75,000/μL</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">患者。</SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">ENABLE 1</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">使用聚乙二醇干扰素</SPAN><SPAN style="WORD-BREAK: normal; LINE-HEIGHT: 21px; WORD-WRAP: normal"><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">α-2a</SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">（</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">Peginterferon alfa-2a</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">。商品名</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">Pegasys</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">，国内注册名：</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">派罗欣）加利巴韦林（</SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">ribavirin</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">）抗病毒治疗。</SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">ENABLE 2</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">则</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">并允许使用聚乙二醇干扰素</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">α-2b</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">（</SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">peginterferon alfa-2b</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">，商品名</SPAN><SPAN lang=EN style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN">PegIntron</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: black; WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">）</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">联合利巴韦林。</SPAN></P>
<P style="BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 0cm 0cm 0pt; WORD-SPACING: 0px; FONT: 14px/21px simsun; TEXT-TRANSFORM: none; COLOR: rgb(85,85,85); WORD-BREAK: normal; TEXT-INDENT: 24pt; PADDING-TOP: 0px; WHITE-SPACE: normal; LIST-STYLE-TYPE: none; LETTER-SPACING: normal; BACKGROUND-COLOR: white; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 0px; WORD-WRAP: normal; border-image: initial; orphans: 2; widows: 2; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px; background-origin: initial; background-clip: initial" align=left><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">Promacta</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">先前的获准适应症为对糖皮质激素、免疫球蛋白或脾切除无足够应答的慢性免疫（特发性）血小板减少症（</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: Arial; WORD-WRAP: normal" xml:lang="EN-US">ITP</SPAN><SPAN style="FONT-SIZE: 12pt; COLOR: rgb(51,51,51); WORD-BREAK: normal; LINE-HEIGHT: 24px; FONT-FAMILY: 宋体; WORD-WRAP: normal">）患者之血小板减少症。</SPAN></P> |
